The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•12 February 2026•

1 min read

LSV Asset Management Boosts Stake in Bristol Myers Squibb

Golden image with multiple screens displaying financial dashboards, charts, and circuit board designs. Upward arrows, microchips, and peace symbols are also visible.

LSV Asset Management has increased its ownership in biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) by 1.7%. The firm acquired an additional 138,119 shares, bringing its total holding to 8,269,472 shares. This strategic move positions BMY as LSV's 22nd largest holding, with an estimated value of $372.95 million. The increased stake follows Bristol Myers Squibb's recent Q4 earnings report, which saw an EPS of $1.26, a revenue beat of $12.5 billion, and a raised quarterly dividend to $0.63 per share. Despite the mixed earnings, LSV's action signals continued confidence in the pharmaceutical company.

Sources: